DB Commodity Double Long ETN due April 1, 2038
DYY was delisted on the 12th of April, 2019.
5 hedge funds and large institutions have $53K invested in DB Commodity Double Long ETN due April 1, 2038 in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
1,225% more capital invested
Capital invested by funds: $4K → $53K (+$49K)
67% more funds holding
Funds holding: 3 → 5 (+2)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$48.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$270 |
DYY Hedge Fund Activity: Q4 2015 in Review
5 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in DB Commodity Double Long ETN due April 1, 2038 (DYY) for Q4 2015, worth a combined $53K — up 1,225% from $4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new DYY positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $48.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $270.
- 5 institutional investors held DB Commodity Double Long ETN due April 1, 2038 (DYY) as of Q4 2015, up from 3 in Q3 2015.
- Funds reported $53K of DB Commodity Double Long ETN due April 1, 2038 stock for Q4 2015, up 1,225% quarter-over-quarter.
- 2 funds opened new DB Commodity Double Long ETN due April 1, 2038 positions in Q4 2015 and 0 closed out, a net change of +2 holders.
- The largest DB Commodity Double Long ETN due April 1, 2038 buyer in Q4 2015 was Citadel Advisors, an estimated $48.2K added.
- The largest DB Commodity Double Long ETN due April 1, 2038 seller in Q4 2015 was Tower Research Capital (TRC), an estimated $270 sold.
Based on aggregated 13F filings for Q4 2015.